Association between nucleated red blood cells in blood and the levels of erythropoietin, interleukin 3, interleukin 6, and interleukin 12p70

Shock

Volumn 24, Issue 1, 2005, Pages 34-39

  Stachon, Axel ^a,b   Bolulu, Orkun ^a   Holland Letz, Tim ^a   Krieg, Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Erythropoietin; IL 3; IL 6; Nucleated red blood cells; Reticulocytes

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 3; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; HIGH RISK POPULATION; HUMAN; HYPOXIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETICULOCYTE; RISK FACTOR; SEX DIFFERENCE; T LYMPHOCYTE;

ADULT; AGED; CELL NUCLEUS; ERYTHROCYTES; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-3; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS;

EID: 21744434742     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000164693.11649.91     Document Type: Article

References (44)

1. Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J: Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer 44:1009-1013, 1979.
2. Andres WA: Normoblastemia after thermal injury. Am J Surg 131:725-726, 1976.
3. Tavassoli M: Erythroblastemia. West. J Med 122:194-198, 1975.
4. Schwartz SO, Stansbury F: Significance of nucleated red blood cells in peripheral blood. J Am Med Assoc 154:1339-1340, 1954.
5. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I: The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. Arch Pathol Lab Med 125:391-396, 2001.
6. Walters J, Garrity P: Performance evaluation of the Sysmex XE-2100 hematology analyser. Lab Hematol 6:83-92, 2000.
7. Briggs C, Harrison P, Grant D, Staves J, Maciag T: New quantitative parameters on recently introduced automated blood cell counter: the XE 2100TM. Clin Lab Haematol 22:345-350, 2000.
8. Stachen A, Sondermann N, Krieg M: Incidence of nucleated red blood cells in the blood of hospitalised patients. Infusion Ther Transfus Med 28:263-266, 2001.
9. Stachon A, Sondermann N, Imöhl M, Krieg M: Nucleated red blood cells indicate high risk for in-hospital mortality. J Lab Clin Med 140:407-412, 2002.
10. Stachon A, Böning A, Krismann M, Weisser H, Laczkovics A, Skipka G, Krieg M: Prognostic significance of erythroblasts in blood after cardiothoracic surgery. Clin Chem Lab Med 39:239-243, 2001.
11. Budmiger H, Graf C, Streuli RA: The leukoerythroblastic blood picture. Incidence and clinical significance. Schweiz Rundsch Med Prax 73:1489-1493, 1984.
12. Weick JK, Hagedorn AB, Linman JW: Leukoerythroblastosis. Mayo Clin Proc 49:110-113, 1974.
13. West CD, Ley AB, Pearson OH: Myelophthisic anemia in cancer of the breast. Am J Med 18:923-931, 1955.
14. Mettier SR: Hematologic aspects of space consuming lesions of the bone marrow (myelophtisic anemia). Ann Intern Med 14:436-448, 1940.
15. Lehnhardt M, Katzy Y, Langer S, Druecke D, Homann HH, Steinstraesser L, Steinau HU, Stachon A: Prognostic significance of erythroblasts in burns. Plast Reconstr Surg 115:120-127, 2005.
16. Erslev AJ: Erythropoietin and anemia of cancer. Eur J Haematol 64:353-358, 2002.
17. Hassan HT, Biermann B, Zander AR: Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11. Eur Cytokine Netw 7:129-136, 1996.
18. Wagemaker G, Burger H, van Gils FC, van Leen RW, Wielenga JJ: Interleukin-3. Biotherapy 2:337-345, 1990.
19. Trey JE, Kushner I: The acute phase response and the hematopoietic system: the role of cytokines. Crit Rev Oncol Hematol 21:1-18, 1995.
20. Koller MR, Bender JG, Miller WM, Papoutsakis ET: Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology (NY) 11:358-363, 1993.
21. Erickson N, Quesenberry PJ: Regulation of erythropoiesis. The role of growth factors. Med Clin North Am 76:745-755, 1992.
22. Reinhardt D, Ridder R, Kugler W, Pekrun A: Post-transcriptional effects of interleukin-3, interferon-γ, erythropoietin and butyrate on in vitro hemoglobin chain synthesis in congenital hemolytic anemia. Haematologica 86:791-800, 2003.
23. Niemeyer CM, Sieff CA, Mathey-Prevot B, Wimperis JZ, Bierer FE, Clark SC, Nathan DG: Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood 73:945-951, 1989.
24. Vreugdenhil G, Lowenberg B, van Eijk HG, Swaak AJ: Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int 10:127-130, 1990.
25. Jongen-Lavrencic M, Peelers HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ: Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 24:1504-1509, 1997.
26. Wittmann M, Zwirner J, Larsson V-A, Kirchhoff K, Begemann G, Kapp A, Götze O, Werfel T: C5a suppressed the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes. J Immunol 162:6763-6769, 1999.
27. Park AY, Scott P: IL-12: keeping cell-mediated immunity alive. Scand J Immunol 53:529-532, 2001.
28. Germann T, Rude E: Interleukin-12. Int Arch Allergy Immunol 108:103-112, 1995.
29. Dybedal I, Larsen S, Jacobsen SE: IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor. J Immunol 154:4950-4955, 1995.
30. Mohan K, Stevenson MM: Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J mice. Exp Hematol 26: 45-52, 1998.
31. Böning A, Stachon A, Weisser H, Krismann M, Skipka G, Laczkowics A, Krieg M: Postoperative cholesterol and erythroblasts as a parameter of perioperative mortality after cardiothoracic surgery. Z Herz-Thorax- Gefässchir 15:242-248, 2001.
32. Thomas L: Erythropoietin. In Thomas L (ed): Clinical Laboratory Diagnostics: Use and Assessment of Clinical Laboratory Results. Frankfurt, Germany: TH-Books, 1998, pp 545-547.
33. Brockow K, Akin C, Huber M, Scott LM, Schwartz LB, Metcalfe DD: Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase. J Allergy Clin Immunol 109:82-88, 2002.
34. Wick M, Kollig E, Walz M, Muhr G, Köller M: Is there a correlation between the release of interleukin-12 and the clinical outcome of polytrauma patients? Chirurg 71:1126-1131, 2000.
35. Guebler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzki AG, Quinn PM, Familetti PC, Gately MK: Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88:4143-4147, 1991.
36. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familetti PC, Sinigaglia F, Chizonnite MK, Guebler U: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147:874-882, 1991.
37. Oleksowicz L, Dutcher JP: A review of the new cytokines: IL-4, IL-6, IL-11, and IL-12. Am J Ther 1:107-115, 1994.
38. Kalinski P, Smits HH, Schuitemaker JHN, Vieira PL, van Eijk M, de Jong EC, Wierenga EA, Kapsenberg ML: IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J Immunol 165:1877-1881, 2000.
39. Mohan K, Stevenson MM: Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production. Br J Haematol 103:942-949, 1998.
40. Volk H-D, Keyssler G, Burmester GR: Cytokines and cytokinereceptors. In Thomas L (ed): Clinical Laboratory Diagnostics: Use and Assessment of Clinical Laboratory Results. Frankfurt, Germany. TH-Books, 1998, pp 764-773.
41. Lacombe C, Mayeux P: Biology of erythropoietin. Haematologica 83:724-732, 1998.
42. Ebert BL, Bunn FH: Regulation of the erythropoietin gene. Blood 94:1864-1877, 1999.
43. Stachon A, Eisenblätter K, Köller M, Holland-Letz T, Krieg M: Cytokines and erythropoietin in the blood of patients with erythroblastemia. Acta Haematol 110:204-206, 2003.
44. Livingston DH, Anjarina D, Wu J, Hauser CJ, Chang V, Deitch EA, Rameshwar P: Bone marrow failure following severe injury in humans. Ann Surg 238:748-753, 2003.